Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in via AAO
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Browse by collection
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Browse by collection
Authors
About
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in via AAO
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 91, Issue 9
Ranibizumab (Lucentis) versus bevacizumab (Avastin): modelling cost effectiveness
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Perspective
Ranibizumab (Lucentis) versus bevacizumab (Avastin): modelling cost effectiveness
Free
Online download statistics by month:
Online download statistics by month: April 2007 to March 2024
Abstract
Full
Pdf
Apr 2007
62
0
158
May 2007
284
0
191
Jun 2007
124
0
126
Jul 2007
72
0
75
Aug 2007
223
444
248
Sep 2007
278
1001
464
Oct 2007
93
339
195
Nov 2007
97
265
137
Dec 2007
82
184
118
Jan 2008
95
268
120
Feb 2008
112
297
130
Mar 2008
102
297
119
Apr 2008
93
238
96
May 2008
77
303
89
Jun 2008
78
345
89
Jul 2008
86
320
96
Aug 2008
76
253
82
Sep 2008
74
308
110
Oct 2008
120
277
106
Nov 2008
113
275
78
Dec 2008
94
175
68
Jan 2009
83
182
82
Feb 2009
65
152
68
Mar 2009
101
250
99
Apr 2009
60
205
75
May 2009
54
143
47
Jun 2009
108
188
61
Jul 2009
71
139
63
Aug 2009
104
120
90
Sep 2009
277
145
93
Oct 2009
539
179
92
Nov 2009
793
194
84
Dec 2009
407
203
73
Jan 2010
116
213
74
Feb 2010
135
252
76
Mar 2010
144
323
107
Apr 2010
101
234
153
May 2010
114
273
148
Jun 2010
152
298
129
Jul 2010
165
285
89
Aug 2010
121
250
96
Sep 2010
91
183
128
Oct 2010
156
233
122
Nov 2010
102
224
139
Dec 2010
61
165
98
Jan 2011
86
228
158
Feb 2011
91
177
153
Mar 2011
121
199
139
Apr 2011
104
131
135
May 2011
101
130
98
Jun 2011
97
113
111
Jul 2011
88
72
57
Aug 2011
68
55
69
Sep 2011
97
68
55
Oct 2011
70
110
85
Nov 2011
128
124
129
Dec 2011
108
79
93
Jan 2012
108
95
93
Feb 2012
71
63
74
Mar 2012
69
60
93
Apr 2012
64
79
47
May 2012
97
75
57
Jun 2012
88
64
57
Jul 2012
61
39
50
Aug 2012
55
23
34
Sep 2012
64
15
32
Oct 2012
89
68
42
Nov 2012
78
57
48
Dec 2012
76
19
24
Jan 2013
126
39
67
Feb 2013
92
21
45
Mar 2013
91
38
38
Apr 2013
91
38
38
May 2013
72
29
35
Jun 2013
48
17
32
Jul 2013
57
26
20
Aug 2013
43
17
21
Sep 2013
48
7
24
Oct 2013
63
14
23
Nov 2013
65
14
30
Dec 2013
47
26
27
Jan 2014
81
61
35
Feb 2014
60
39
35
Mar 2014
83
30
38
Apr 2014
74
20
40
May 2014
75
9
27
Jun 2014
47
11
27
Jul 2014
67
36
16
Aug 2014
25
42
16
Sep 2014
14
21
11
Oct 2014
28
45
14
Nov 2014
16
39
17
Dec 2014
20
28
24
Jan 2015
22
40
14
Feb 2015
15
35
18
Mar 2015
53
52
22
Apr 2015
31
46
16
May 2015
19
59
18
Jun 2015
17
21
13
Jul 2015
19
18
11
Aug 2015
14
25
12
Sep 2015
17
23
10
Oct 2015
17
21
8
Nov 2015
24
23
10
Dec 2015
25
36
13
Jan 2016
36
35
14
Feb 2016
22
44
18
Mar 2016
22
37
15
Apr 2016
22
31
30
May 2016
3
23
9
Jun 2016
12
22
5
Jul 2016
26
12
15
Aug 2016
29
26
12
Sep 2016
25
22
15
Oct 2016
23
29
13
Nov 2016
17
24
15
Dec 2016
20
15
14
Jan 2017
23
10
12
Feb 2017
14
2
8
Mar 2017
20
9
12
Apr 2017
26
27
15
May 2017
10
24
5
Jun 2017
20
22
5
Jul 2017
24
16
7
Aug 2017
66
36
14
Sep 2017
120
82
12
Oct 2017
237
186
15
Nov 2017
108
80
10
Dec 2017
126
112
4
Jan 2018
241
189
8
Feb 2018
148
119
15
Mar 2018
151
133
24
Apr 2018
126
92
12
May 2018
117
81
16
Jun 2018
139
105
9
Jul 2018
175
147
8
Aug 2018
161
139
8
Sep 2018
167
151
7
Oct 2018
146
104
13
Nov 2018
145
123
14
Dec 2018
131
113
3
Jan 2019
119
89
10
Feb 2019
135
91
22
Mar 2019
94
38
18
Apr 2019
51
23
26
May 2019
71
51
22
Jun 2019
106
79
11
Jul 2019
84
68
12
Aug 2019
116
76
18
Sep 2019
84
70
11
Oct 2019
129
76
33
Nov 2019
96
74
17
Dec 2019
120
83
11
Jan 2020
93
65
8
Feb 2020
137
89
14
Mar 2020
76
64
17
Apr 2020
101
83
10
May 2020
143
108
20
Jun 2020
82
70
25
Jul 2020
82
64
6
Aug 2020
61
57
5
Sep 2020
87
71
3
Oct 2020
90
70
4
Nov 2020
32
17
16
Dec 2020
108
64
11
Jan 2021
35
22
14
Feb 2021
36
20
13
Mar 2021
46
24
26
Apr 2021
52
28
13
May 2021
18
13
4
Jun 2021
21
20
12
Jul 2021
24
24
14
Aug 2021
17
15
6
Sep 2021
21
21
22
Oct 2021
57
21
41
Nov 2021
52
20
24
Dec 2021
44
22
6
Jan 2022
47
36
14
Feb 2022
46
31
11
Mar 2022
52
29
17
Apr 2022
59
29
15
May 2022
93
48
22
Jun 2022
67
36
9
Jul 2022
52
34
9
Aug 2022
47
25
7
Sep 2022
62
43
20
Oct 2022
80
39
14
Nov 2022
81
29
14
Dec 2022
51
25
8
Jan 2023
61
39
12
Feb 2023
73
39
7
Mar 2023
48
20
7
Apr 2023
84
30
23
May 2023
43
23
14
Jun 2023
30
9
12
Jul 2023
25
15
14
Aug 2023
37
19
20
Sep 2023
28
12
6
Oct 2023
57
25
9
Nov 2023
56
33
9
Dec 2023
55
27
6
Jan 2024
54
24
11
Feb 2024
29
13
8
Mar 2024
37
25
113
Total
17412
18900
9386
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in via AAO
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF